Literature DB >> 22067180

Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy.

Doenja M J Lambregts1, Monique Maas, Frans C H Bakers, Vincent C Cappendijk, Guido Lammering, Geerard L Beets, Regina G H Beets-Tan.   

Abstract

BACKGROUND: The "wait-and-see" policy instead of standard surgery for patients with rectal cancer who undergo a complete tumor regression after chemoradiation treatment is highly controversial. It is not clear yet how patients should be monitored once they are managed nonoperatively and whether follow-up by MRI has any potential role.
OBJECTIVE: This study aimed to describe the rectal wall MRI morphology during short-term and long-term follow-up in patients with a clinical complete tumor response undergoing a wait-and-see policy without surgical treatment. DESIGN, SETTING, AND PATIENTS: As part of an observational study in our center, a cohort of 19 carefully selected patients with a clinical complete response after chemoradiation was managed with a wait-and-see policy and followed regularly (every 3-6 mo) by clinical examination, endoscopy with biopsies, and a rectal MRI. The MR morphology of the tumor bed was studied on the consecutive MRI examinations. MAIN OUTCOME MEASURES: The primary outcome measured was the morphology of the tumor bed on the consecutive MRI examinations performed during short-term (≤6 mo) and long-term (>6 mo) follow-up.
RESULTS: Patients with a complete tumor response after chemoradiation presented with either a normalized rectal wall (26%) or fibrosis (74%). In the latter group, 3 patterns of fibrosis were observed (full-thickness, minimal, or spicular fibrosis). The morphology patterns of a normalized rectal wall or fibrosis remained consistent during long-term follow-up in 18 of 19 patients. One patient developed a small, endoluminal recurrence, which was salvaged with transanal endoscopic microsurgery. In 26% of patients, an edematous wall thickening was observed in the first months after chemoradiation, which gradually decreased during long-term follow-up. Median follow-up was 22 months (range, 12-60). LIMITATIONS: This was a small observational study, and had no histological validation.
CONCLUSIONS: Four MR patterns of a persistent complete response of rectal cancer after chemoradiation were identified. These MR features can serve as a reference for the follow-up in a wait-and-see policy.

Entities:  

Mesh:

Year:  2011        PMID: 22067180     DOI: 10.1097/DCR.0b013e318232da89

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  26 in total

Review 1.  [The role of cross-sectional imaging in staging of rectal cancer].

Authors:  A O Schäfer; M Langer; T Baumann
Journal:  Chirurg       Date:  2012-05       Impact factor: 0.955

Review 2.  Local Excision and Endoscopic Resections for Early Rectal Cancer.

Authors:  Guilherme Pagin São Julião; Juan Pablo Celentano; Flavia Andrea Alexandre; Bruna Borba Vailati
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 3.  Management of the Complete Clinical Response.

Authors:  Angelita Habr-Gama; Guilherme Pagin São Julião; Bruna Borba Vailati; Ivana Castro; Debora Raffaele
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

4.  MRI surveillance for the detection of local recurrence in rectal cancer after transanal endoscopic microsurgery.

Authors:  Britt J P Hupkens; Monique Maas; Milou H Martens; Willem M L L G Deserno; Jeroen W A Leijtens; Patty J Nelemans; Frans C H Bakers; Doenja M J Lambregts; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

5.  SSAT State-of-the-Art Conference: Advances in the Management of Rectal Cancer.

Authors:  Evie Carchman; Daniel I Chu; Gregory D Kennedy; Melanie Morris; Marc Dakermandji; John R T Monson; Laura Melina Fernandez; Rodrigo Oliva Perez; Alessandro Fichera; Marco E Allaix; David Liska
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

6.  Management of distal rectal cancer: results from a national survey.

Authors:  G Melotti; E De Antoni; A Habr-Gama; A Minicozzi
Journal:  Updates Surg       Date:  2013-01-19

7.  Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging.

Authors:  R O Perez; A Habr-Gama; G P São Julião; P B Lynn; C Sabbagh; I Proscurshim; F G Campos; J Gama-Rodrigues; S C Nahas; C A Buchpiguel
Journal:  Tech Coloproctol       Date:  2014-02-08       Impact factor: 3.781

8.  Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer.

Authors:  C Pericay; X Serra-Aracil; J Ocaña-Rojas; L Mora-López; E Dotor; A Casalots; A Pisa; E Saigí
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

Review 9.  Watch and wait approach to rectal cancer: A review.

Authors:  Marcos E Pozo; Sandy H Fang
Journal:  World J Gastrointest Surg       Date:  2015-11-27

10.  Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?

Authors:  Aurelie Garant; Livia Florianova; Adrian Gologan; Alan Spatz; Julio Faria; Nancy Morin; Carol-Ann Vasilevsky; Te Vuong
Journal:  Int J Colorectal Dis       Date:  2018-03-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.